El Futuro en el Tratamiento del Cáncer Renal - page 21

Targeting Renal Cell carcinoma

Adapted from Kerkar & Restifo. Cancer Res 2012



VHL-driven angiogenesis



Immuno-Oncology Drugs



Metabolic & signalling

pathways



Cell cycle & epigenetics



Tumor stroma & radionuclides

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,11,12,13,14,15,16,17,18,19,20 22,23,24,25,26,27,28,29,30,31,...36